Cell-Based Assays Using Differentiated Human Induced Pluripotent Cells.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2019
Historique:
entrez: 25 5 2019
pubmed: 28 5 2019
medline: 13 3 2020
Statut: ppublish

Résumé

This chapter describes the requirements and preconditions for using human induced pluripotent cell lines in assay development within the pharmaceutical industry. The joint collaborative effort between academic and pharma partners within the StemBANCC consortium which enabled the implementation of iPSC-derived cellular models for drug discovery is highlighted. This large collaborative scientific network has successfully derived a significant number of well-characterized patient-specific iPSC lines and established disease-relevant cellular assays, both of which are requirements for enabling pharmaceutical companies to develop more efficacious and safer medicines.

Identifiants

pubmed: 31124100
doi: 10.1007/978-1-4939-9477-9_1
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-14

Auteurs

Zameel Cader (Z)

Translational Molecular Neuroscience Group, Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.

Martin Graf (M)

Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

Mark Burcin (M)

Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

Carl-Fredrik Mandenius (CF)

Division of Biotechnology, Department of Physics, Chemistry and Biology (IFM), Linköping University, Linköping, Sweden.

James A Ross (JA)

Tissue Injury and Repair Group, University of Edinburgh, Edinburgh, UK. j.a.ross@ed.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH